This diagnostic procedure is a specific type of cardiac stress test used to assess blood flow to the heart muscle. It combines pharmacological stress induced by a vasodilator with myocardial perfusion imaging. The pharmacological agent stimulates the effects of exercise on the heart, increasing heart rate and dilating coronary arteries. Simultaneously, a radioactive tracer is injected, allowing for images to be captured that reveal areas of the heart receiving adequate blood supply and identifying areas potentially affected by blockages or reduced blood flow. This combination offers a non-invasive method for evaluating cardiac function, particularly in individuals unable to undergo traditional exercise stress tests.
The importance of this method lies in its ability to accurately identify coronary artery disease. The diagnostic information derived from the images helps physicians assess the severity of any existing blockages and determine the most appropriate treatment strategies, which may range from lifestyle modifications and medication to more invasive procedures such as angioplasty or bypass surgery. Its benefits include a reduced risk compared to more invasive diagnostic techniques and the ability to provide valuable information about heart function in patients with physical limitations. The application of pharmacological stress testing in conjunction with nuclear imaging has become increasingly prevalent due to its effectiveness and relative safety.
